Related Experiment Video
Updated: Aug 23, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
No evidence for links between autism, MMR and measles virus
1Institute of Psychiatry, King's College and Department of Child and Adolescent Psychiatry, Guy's, King's and St Thomas's School of Medicine, University of London.
Background:
We examined whether, in the UK, there is an increased risk of autism (AD) following exposures, in early life, to: (1) wild measles; (2) live attenuated measles, alone or in combination as MMR; and (3) the alteration of the mumps strain within MMR.
Method:
We conducted time trend analyses of 2407 AD subjects born between 1959-93; and for comparison, 4640 Down's syndrome (DS) subjects born between 1966-93. Between 1968-86, we correlated variations in AD and DS births with wild measles incidence. Between 1959-93, we tested for abrupt changes in the long-term AD birth trend for the effects of introducing: (1) monovalent measles vaccines in 1968; (2) MMR immunization in 1988; and (3) the 'overnight switch' from mixed use of Urabe MMR to exclusive use of Jeryl-Lynn MMR in 1992. Incidence rate ratios (IRRs) were used as measures of association.
Results:
We found no significant association between AD births and exposure (prenatal and postnatal up to 18 months age) to population rates of measles infections, and no 'step-up' increase in AD births associated with the introduction of monovalent measles and MMR vaccines, and changing mumps strain. An unexpected reduction in AD births of 21% (95% CI 6.9-33.3%; P=0.005) among the post-1987 birth cohorts was detected.
Conclusion:
No increased risk of AD following exposures to wild measles and vaccinations with monovalent measles, and Urabe or Jeryl-Lynn variants of MMR was detected. The precise meaning of the detected AD births reduction is unclear. Our study cannot exclude rare complications of MMR, given its correlational design.
Insights
This UK study found no increased autism risk from measles infections or vaccines, including MMR. Unexpectedly, autism diagnoses decreased by 21% in later birth cohorts.
Area of Science:
- Epidemiology
- Public Health
- Immunization Studies
Background:
- Investigated potential links between early-life exposures to measles and autism risk in the UK.
- Examined risks associated with wild measles, live attenuated measles vaccines, and MMR (measles, mumps, rubella) vaccine components.
Purpose of the Study:
- To determine if measles exposure or vaccination increases autism (AD) risk.
- To assess the impact of MMR vaccine introduction and mumps strain changes on AD incidence.
Main Methods:
- Time trend analyses of autism and Down's syndrome (DS) births (1959-1993).
- Correlated measles incidence with AD and DS births (1968-1986).
- Analyzed AD birth trends for impacts of monovalent measles vaccine (1968) and MMR (1988, 1992).
Main Results:
- No significant association found between AD births and measles infection exposure.
- No increase in AD births linked to monovalent measles or MMR vaccine introduction.
- A significant 21% reduction in AD births observed in post-1987 cohorts.
Conclusions:
- No evidence of increased autism risk from wild measles or measles-containing vaccines (MMR).
- The cause of the observed reduction in autism diagnoses remains unclear.
- Correlational design cannot rule out rare MMR complications.
Related Concept Videos
Vaccinations
Viral Meningitis
Poliomyelitis
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Encephalitis l: Introduction
